Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

Why Snap lost more than $2 billion in three months

Short answer: It paid its employees — including CEO Evan Spiegel — $2 billion in stock.

American Magazine Media Conference - Day 1
American Magazine Media Conference - Day 1
Larry Busacca/Getty Images for Time Inc
Peter Kafka
Peter Kafka covered media and technology, and their intersection, at Vox. Many of his stories can be found in his Kafka on Media newsletter, and he also hosts the Recode Media podcast.

How do you lose more than $2 billion in your first quarter as a public company?

By paying out $2 billion in stock to your employees.

That’s the short story behind the $2.2 billion first-quarter loss Snap posted today. The bulk of that came from $2 billion in stock that the company recognized on its books on the date of its “qualifying event” — when it went public earlier this year.

If you pull out those payments, and some other costs, Snap’s loss is a more palatable $188 million. Which is the way Snap would prefer that investors look at things:

Snap adjusted EBITDA chart

About the $2 billion: Much of that came from the “CEO award” that Snap’s investors gave Evan Spiegel as a reward for taking the company public. But Spiegel’s award didn’t represent the bulk of that sum.

In the last proxy statement Snap filed before going public, Snap estimated the value of Spiegel’s award at more than $550 million, and said it had another $1.1 billion in employee stock awards that would kick in after the IPO. We should get a more accurate breakdown when Snap files its first quarterly report with the SEC, but let’s use those numbers as a placeholder for now.

It is also worth noting that the seemingly dull issue of stock-based compensation has become a big deal for Silicon Valley companies in the last year or so.

Short version: For a long time, tech companies tried to argue that investors shouldn’t worry about the stock they paid their employees, because it didn’t represent the “real” cost of running their business. For various reasons, several prominent tech companies, including Alphabet and Facebook, are now including stock comp in their numbers.

In any event, Snap told Wall Street that those expenses were coming, so that’s not what’s dragging the stock down despite what, um, people said on Twitter. (Never tweet.)

Wall Street is worried, first and foremost, about Snap’s user numbers and whether all the Snap cloning Facebook has engaged in over the last few months has cut into Snap’s user base.


This article originally appeared on Recode.net.

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh